Vitamin B3 Market 2022 Growth, Survey, Share, Company Profiles and Forecast by 2030 | Lonza Group AG, (Europe), Jiangsu Brother Vitamin Co. Ltd., (China)

The vitamin B3 market is expected to elevate at a compound annual growth rate (CAGR) of 2.8% over the forecast period from 2021-2030.

New York (United states):- Report Ocean published the latest research report on the Vitamin B3 market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Vitamin B3 market study demonstrates a detailed examination of the business state, which represents creative ways for company growth, financial factors such as production value, key regions, and growth rate.

The vitamin B3 market is expected to elevate at a compound annual growth rate (CAGR) of 2.8% over the forecast period from 2021-2030.

Request To Download Sample of This Strategic Report:-

The growing number of poor health conditions is driving the growth of the vitamin B3 market. This is attributed to poor health conditions like irritability, anxiety, poor concentration, fatigue, apathy, restlessness, depression. Over 275 million people are affected by anxiety disorders, which account for over 4% of the global population. Moreover, according to the Anxiety & Depression Association of America, Anxiety disorders have affected over 40 million adults in the United States, which makes it the most common mental illness found in the population. Thus, the anxiety treatments will ultimately raise chances for the consumption of B3 vitamins.

Moreover, chronic diseases can cause severe deficiency of B3 vitamins in the body. Crohn’s disease can also lead to the deficiency of the B3 vitamin. Over 800,000 Americans suffer from Crohn’s disease. These factors are expected to exhibit some promising growth in the global Vitamin B3 market. Apart from that, cancer patients, HIV patients, and people undergoing dialysis treatment are more prone to niacin (Vitamin B3) deficiency. Due to this, the global vitamin B3 market is expected to boost during the forecast period.

According to the National Kidney Foundation, around 2 million people undergo dialysis treatment or kidney transplantation worldwide. Such treatments and diseases can further fuel the growth of the global vitamin B3 market.

Moreover, the rising number of skin diseases and problems related to the digestive system and nervous system will exceed the demand for vitamin B3. Around 440 million cases of acute noncancerous medical conditions are registered in the United States annually. Apart from that, around 75%mental disorder cases in developing countries are not getting proper treatment. Moreover, World Health Organization (WHO) estimates that 1 out of 13 suffers from an anxiety disorder. The treatment of these diseases will automatically boost the demand for Vitamin B3.

COVID-19 Impact Analysis

In response to the COVID-19 outbreak, people took on additional measures to strengthen their immunity, resulting in a greater need for vitamin B3. However, disruptions in the supply chain due to lockdown slightly hampered the growth of the market.

Request To Download Sample of This Strategic Report:-

Regional Analysis

North America is dominating the global vitamin B3 market. A wide range of product offerings and the rise in mental & physical illness are key factors contributing to the market’s growth. Apart from that, Asia Pacific would forecast the most active growth in the global vitamin B3 market because of the pervasiveness of chronic diseases, boosting demand for health and nutritional supplements among the people in this region.

Market Segmentation

By Type

Feed Grad

Pharmaceutical Grade

By Application





By Source



By Form



Get a Sample PDF copy of the report:-

By Region

North America

The U.S.




Western Europe

The UK





Rest of Western Europe

Eastern Europe



Rest of Eastern Europe

Asia Pacific




Australia & New Zealand


Rest of Asia Pacific

Middle East & Africa (MEA)


Saudi Arabia

South Africa

Rest of MEA

South America



Rest of South America

Key Players

Shandong Hongda Biotechnology Co., Ltd., (China)

Lonza Group AG, (Europe)

Jiangsu Brother Vitamin Co. Ltd., (China)

Lasons India, (India)

NutraScience Labs, (United States)

Spectrum Chemical Mfg. Corp, (United States)

Jubilant Life Sciences Ltd, (India)

Vertellus, (United States)

The Chemical Co., (United States)

Other prominent players

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Access full Report Description, TOC, Table of Figure, Chart, etc.-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)

Back to top button